DUBLIN--(BUSINESS WIRE)--The "Global Crohn's Disease Diagnostic and Therapeutic Market - Segmented by Type of Disease, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The global Crohn's disease diagnostic and therapeutic market is estimated to grow at a good CAGR during the forecast period.
It is estimated that around 1.6 million Americans have the inflammatory bowel disease. This number includes about 780,000 of the population who have Crohn's disease, and another 907,000 people with ulcerative colitis. Research suggests that about six to 15 new cases of Crohn's disease are diagnosed per 100,000 people each year. People are most frequently diagnosed with Crohn's disease and ulcerative colitis in the late adolescence or in early adulthood, even though the diagnosis may happen at any age.
Current costs for the treatment and diagnosis of Crohn's disease is high, due to the availability of several new therapeutic drugs and changes in the surgical treatment of the disease. For example, the total cost of Crohn's disease in the United States is around USD 3.6 billion every year, and the average yearly medical cost per patient is about USD 8,265, with more than one-third of that cost being medications. Biologic medications or drugs are usually expensive. Hospitalization accounted for 31.4% of the cost. On an average, people who have to be hospitalized for Crohn's disease are expected to spend about 5.8 days in the hospital.
North America is dominating the Crohn's disease diagnostic and therapeutic market due to the increasing prevalence of Crohn's disease in the region. Asia-Pacific is expected to record a substantial growth in the forecast period.
Companies Mentioned
- Abbvie
- Celgene Corporation
- Genentech
- Janssen Biotech Inc.
- Pfizer Inc.
-
Prometheus Laboratories Inc.
-
Salix Pharmaceuticals Inc.
- Takeda's Pharmaceutical Ltd
- Johnson & Johnson
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
11. Disclaimer
For more information about this report visit https://www.researchandmarkets.com/research/mpmfbx/global_crohns?w=4
